Imported Lassa fever in Germany: Molecular characterization of a new Lassa virus strain

Emerging Infectious Diseases

Volumn 6, Issue 5, 2000, Pages 466-476

  Günther, Stephan ^a   Emmerich, Petra ^a   Laue, Thomas ^a   Kühle, Olaf ^a   Asper, Marcel ^a   Jung, Annegret ^a   Grewing, Thomas ^a   Ter Meulen, Jan ^a   Schmitz, Herbert ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ARENAVIRUS; ARTICLE; CASE REPORT; FEMALE; GENE AMPLIFICATION; GERMANY; HUMAN; LASSA FEVER; LASSA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; VIRAL GENETICS; VIRUS CHARACTERIZATION; VIRUS ISOLATION; VIRUS STRAIN;

EID: 0033772501     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0605.000504     Document Type: Article

References (43)

1. Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria
2. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings
3. Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases
4. A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972
5. Lassa fever in the United States. Investigation of a case and new guidelines for management
6. Lassa fever: The first confirmed case imported into Canada
7. Lassa fever: Response to an imported case
8. An imported case of Lassa fever with late appearance of polyserositis
9. Identification of Lassa fever virus infection with recombinant nucleocapsid protein antigen
10. Imported Lassa fever: Reexamining the algorithms
11. Phylogenetic analysis of the Arenaviridae: Patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts
12. Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates
13. Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies
14. Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization
15. Nucleotide sequence of the Lassa virus (Josiah strain) S genome RNA and amino acid sequence comparison of the N and GPC proteins to other arenaviruses
16. Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products
17. Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use
18. Early diagnosis of Lassa fever by reverse transcription-PCR
19. Lassa fever, case imported to Germany
20. Epitope mapping of the Lassa virus nucleoprotein using monoclonal antinucleocapsid antibodies
21. A case-control study of the clinical diagnosis and course of Lassa fever
22. Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus
23. Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5' end
24. Amplification of full-length hepatitis B virus genomes from samples from patients with low levels of viremia: Frequency and functional consequences of PCR-introduced mutations
25. Deleted viral RNAs and lymphocytic choriomeningitis virus persistence in vitro
26. Lassa virus glycoproteins: Antigenic and immunogenic properties of synthetic peptides to GP1
27. Fine mapping of a peptide sequence containing an antigenic site conserved among arenaviruses
28. Site-specific antibodies define a cleavage site conserved among arenavirus GP-C glycoproteins
29. The localization and preliminary characteristics of antigenic sites (B epitopes) in the nucleocapsid protein of the Lassa virus
30. Characterization of human CD4+ T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein
31. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes
32. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome
33. A single nucleotide change in the 5' noncoding region of Sindbis virus confers neurovirulence in rats
34. Resistance to alpha/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5'noncoding region and glycoproteins
35. Sequence analysis of the S RNA of the African arenavirus Mopeia: An unusual secondary structure feature in the intergenic region
36. Generation of reassortants between African arenaviruses
37. Lassa fever: Implications of T-cell immunity for vaccine development
38. Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene
39. Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever
40. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus
41. Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus